In 2016, the tenth year of quadrivalent human papillomavirus (HPV) vaccine delivery in Australia by the national immunisation program, it is encouraging to report recent increases in HPV vaccine coverage recorded by the National HPV Vaccination Program Register (NHVPR). The program commenced in April 2007, with a catch-up program for all females aged 12–26 years until the end of 2009, and routine school vaccination at age 12–13 thereafter. In 2013, routine immunisation of boys (12–13 years) against HPV commenced, with a 2-year catch-up program for boys up to 15 years old. Quadrivalent HPV vaccine is routinely given at school to both girls and boys aged 12–13 years, with a three-dose schedule. The NHVPR maintains records of HPV vaccinations, and there is almost complete notification of school doses. Coverage is routinely reported at age 15, as recommended by the World Health Organization and to facilitate consistency in national reporting (the age of vaccination and course completion varies slightly between states and territories). The NHVPR uses Australian Bureau of Statistics estimated resident population data as the denominator for calculating coverage. Notification of doses delivered in general practice is not compulsory, resulting in some undernotification.1
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Gertig DM, Brotherton JML, Saville M. Methods for measuring HPV vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sex Health 2011; 8: 171-178.
- 2. Watson M, D’Onise K, Lynch J, Brotherton JML. What are the barriers to better three-dose coverage with HPV vaccination in school based programs? Aust N Z J Public Health 2014; 38: 91-92.
- 3. Mak DB, Bulsara MK, Wrate MJ, et al. Factors determining vaccine uptake in Western Australian adolescents. J Paediatr Child Health 2012; 49: 895-900.
- 4. Staples C, Butler M, Nguyen J, et al. Opportunities to increase rates of human papillomavirus vaccination in the New South Wales school program through enhanced catch-up. Sex Health 2016; 13: 536-539.
- 5. World Health Organization. Human papillomavirus vaccines: WHO position paper, October 2014. Wkly Epidemiol Rec 2014; 89: 465-491.
Julia Brotherton and Marion Saville have been investigators on investigator-initiated unrestricted research projects partly funded by Seqirus and Merck.